Blue Owl logo

Blue Owl

North America, New York, United States, New York

Description

Blue Owl is an alternative asset manager that provides investors access to direct lending and GP capital solutions.

Investor Profile

Blue Owl has made 41 investments, with 26 in the past 12 months and 39% as lead.

Stage Focus

  • Post Ipo Equity (24%)
  • Debt Financing (22%)
  • Series B (12%)
  • Series C (10%)
  • Post Ipo Debt (10%)
  • Series A (5%)
  • Series Unknown (5%)
  • Private Equity (5%)
  • Series F (2%)
  • Series D (2%)

Country Focus

  • United States (80%)
  • United Kingdom (10%)
  • Canada (5%)
  • Spain (2%)
  • Switzerland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Medical
  • Information Technology
  • Financial Services
  • Oncology
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Blue Owl frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 4
RTW Investments
North America, New York, United States, New York
Co-Investments: 6
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 4
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 9
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 5
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 4
Invus
North America, New York, United States, New York
Co-Investments: 6
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 4

Which angels does Blue Owl often collaborate with?

Shared Deals: 1

What are some of recent deals done by Blue Owl?

Eagle Pharmaceuticals

Woodcliff Lake, New Jersey, United States

Eagle Pharmaceuticals is a company focused on developing and commercializing injectable products in the critical care and oncology areas.

BiotechnologyHealth CareOncologyPharmaceutical
Post Ipo DebtMar 31, 2025
Amount Raised: $69,000,000
Latigo Biotherapeutics

Thousand Oaks, California, United States

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 17, 2025
Amount Raised: $150,000,000
Capital on Tap

London, England, United Kingdom

Capital on Tap is a fintech company that provides small businesses with credit cards and a spend management platform.

Credit CardsFinanceFinancial ServicesFinTech
Debt FinancingFeb 21, 2025
Amount Raised: $947,474,538
Databricks

San Francisco, California, United States

Databricks is an AI cloud data platform that interacts with corporate information stored in the public cloud.

AnalyticsArtificial Intelligence (AI)Information TechnologyMachine Learning
Debt FinancingJan 13, 2025
Amount Raised: $5,250,000,000
Trillium Flow Technologies

Glasgow, Glasgow City, United Kingdom

Trillium Flow Technologies is a global designer, manufacturer and aftermarket services provider of pumps and valves.

Industrial EngineeringManufacturingMechanical Engineering
Debt FinancingJan 13, 2025
Windward Bio

Basel, Basel-Stadt, Switzerland

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

BiotechnologyLife ScienceMedical
Series AJan 10, 2025
Amount Raised: $200,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $75,000,000
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Post Ipo EquityDec 13, 2024
BITKRAFT Ventures

San Francisco, California, United States

BITKRAFT Ventures is an early-stage investment platform for gaming, esports, and interactive media.

Digital EntertainmenteSportsVenture CapitalVideo GamesVirtual Reality
Private EquityDec 5, 2024